Block trade of shares in I-Tech AB (SE) — SEK 78 million

Carnegie acted as sole broker in the block trade of total 1.9 million ordinary shares in I-Tech at a price of SEK 40 per share. I-Tech AB is a public held bio-technology company based in Mölndal, Sweden that owns all IP and regulatory rights to the antifouling agent Selektope® (generic name, medetomidine). September 2019.